(Q33753228)

29 July 2017

1 reference

title

Neuroimaging in neuropsychiatric systemic lupus erythematosus (English)

1 reference

neuropsychiatric systemic lupus erythematosus

29 July 2017

0 references

0 references

author name string

Sibbitt WL Jr

series ordinal

1

1 reference

PubMed ID

10524673

29 July 2017

Sibbitt RR

series ordinal

2

1 reference

PubMed ID

10524673

29 July 2017

Brooks WM

series ordinal

3

1 reference

29 July 2017

1 October 1999

1 reference

29 July 2017

Arthritis & Rheumatology

1 reference

29 July 2017

42

1 reference

29 July 2017

10

1 reference

29 July 2017

2026-2038

1 reference

The neuropsychiatric manifestations of systemic lupus erythematosus: an overview

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Nervous system involvement in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Diagnosis and pathogenesis of CNS lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Large cerebral vessel occlusive disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Interferon-alpha in lupus psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Disseminated perivenous necrotizing encephalomyelitis in systemic lupus erythematosus: report of an autopsy case

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Controversies in lupus: nervous system involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Cerebral occlusive vasculopathy in systemic lupus erythematosus and speculation on the part played by complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Brain calcification in patients with cerebral lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Massive cerebral calcification in systemic lupus erythematosus: report of an unusual case.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

A reversible posterior leukoencephalopathy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Unusual neuroradiological findings in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Systemic lupus erythematosus. A prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Parkinsonian syndrome complicating systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Pseudotumour cerebri in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Treatable intracranial hypertension in patients with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

MR imaging of systemic lupus erythematosus involving the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Angiographic demonstration of major cerebral vessel occlusion in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Structural and neurochemical markers of brain injury in the migraine diathesis of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Brain injury and neurometabolic abnormalities in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Patients with antiphospholipid antibodies: CT and MR findings of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Resolving MRI lesions in lupus erythematosus selectively involving the brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Automated T2 quantitation in neuropsychiatric lupus erythematosus: a marker of active disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Repeat cerebral blood volume assessment with first-pass MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Reproducibility of 1H-MRS in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

N-acetylaspartate reductions measured by 1H MRSI in cognitively impaired HIV-seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Multivoxel 1H-MRS of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Proton MR spectroscopy of gadolinium-enhanced multiple sclerosis plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Quantitative proton MRS predicts outcome after traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

The biochemistry of human diseases as studied by 31P NMR in man and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

P-31 Nuclear Magnetic Resonance Analysis of Brain: The Perchloric Acid Extract Spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

21 January 2018

In situ brain metabolism

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

An approach to the problem of metabolic heterogeneity in brain: ischemia and reflow after ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Quantitative electroencephalography. A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Accuracy of 133-xenon regional cerebral blood flow and quantitative electroencephalography in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Prognostic significance of quantitative electroencephalography in Alzheimer patients: preliminary observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Brain scan findings in central nervous system involvement by lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Brain scan diagnosis of central nervous system involvement in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Quantitation of local cerebral blood flow and partition coefficient without arterial sampling: theory and validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Positron emission tomography in neuropsychiatric lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Regional cerebral glucose metabolism in SLE chorea: further evidence that striatal hypometabolism is not a correlate of chorea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Correction of positron emission tomography data for cerebral atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Global cerebral blood flow, blood volume, and oxygen metabolism in patients with migraine headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Focal abnormalities detected by 18FDG PET in epileptic encephalopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Regional Cerebral Blood Flow Estimated by 133 Xenon Inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Cerebral blood flow in systemic lupus erythematosus with or without cerebral complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Cerebral blood flow in systemic lupus erythematosus with and without central nervous system involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Serial single photon emission computed tomography imaging in patients with cerebral lupus during acute exacerbation and after treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Evaluation of patients with CNS involvement in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Regional cerebral blood flow in chronic stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2026%3A%3AAID-ANR2%3E3.0.CO%3B2-J

10.1002/1529-0131(199910)42:10<2026::AID-ANR2>3.0.CO;2-J

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10524673